Background and purpose Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for
90 days was recommended as the secondary prevention of minor ischaemic strokes or …

Objective: We compared the effect of clopidogrel plus aspirin vs aspirin alone on functional
outcome and quality of life in the Clopidogrel in High-risk Patients with Acute Non-disabling …

Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Objective To study the early time course of major bleeding and its subtypes in patients with
cerebral ischemia on dual and single antiplatelet therapy. Methods We performed a post hoc …

Importance Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin is effective in
preventing recurrent strokes after minor ischemic stroke or transient ischemic attack (TIA) …

Background and Purpose: Randomized trials demonstrated the benefit of dual antiplatelet
therapy in patients with minor ischemic stroke or high-risk transient ischemic attack. We …

Background: Dual-antiplatelet regimens for prevention of recurrent stroke promote
antithrombotic effects but may increase the risk for hemorrhage. Purpose: To qualitatively …

Objective: To estimate the association of different patterns of infarction and intracranial
arterial stenosis (ICAS) with the prognosis of acute minor ischemic stroke and TIA. Methods …

Background and Purpose—Two large-scale randomized controlled trials of recurrent stroke
prevention suggest that dual antiplatelet therapy with clopidogrel plus aspirin is beneficial …

Background Treatment with the combination of clopidogrel and aspirin taken soon after a
transient ischemic attack (TIA) or minor stroke was shown to reduce the 90‐day risk of stroke …